Published in J Immunol on December 12, 2014
The Size of Activating and Inhibitory Killer Ig-like Receptor Nanoclusters Is Controlled by the Transmembrane Sequence and Affects Signaling. Cell Rep (2016) 0.79
Zinc-Induced Polymerization of Killer-Cell Ig-like Receptor into Filaments Promotes Its Inhibitory Function at Cytotoxic Immunological Synapses. Mol Cell (2016) 0.75
Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C. Front Immunol (2017) 0.75
Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell (2002) 10.81
Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature (2005) 7.40
Human NK cell education by inhibitory receptors for MHC class I. Immunity (2006) 6.73
Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc (2006) 5.81
A viral inhibitor of peptide transporters for antigen presentation. Nature (1995) 4.26
Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 3.38
Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity (1996) 3.33
Identification of new fluorescent protein fragments for bimolecular fluorescence complementation analysis under physiological conditions. Biotechniques (2006) 2.99
The kinetic-segregation model: TCR triggering and beyond. Nat Immunol (2006) 2.70
Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol (2001) 2.52
Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev (2008) 2.40
Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol (2003) 2.15
Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity (2008) 2.03
The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med (1997) 1.91
Plasmonics in Biology and Plasmon-Controlled Fluorescence. Plasmonics (2006) 1.90
Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol (1996) 1.90
Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity (1996) 1.87
How IGF-1 activates its receptor. Elife (2014) 1.74
Visualization of molecular interactions using bimolecular fluorescence complementation analysis: characteristics of protein fragment complementation. Chem Soc Rev (2009) 1.74
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood (2009) 1.62
An improved bimolecular fluorescence complementation assay with a high signal-to-noise ratio. Biotechniques (2010) 1.48
Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr Biol (1998) 1.31
Adhesion to target cells is disrupted by the killer cell inhibitory receptor. Curr Biol (2000) 1.27
Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells. J Cell Biol (2011) 1.26
Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets. J Exp Med (1999) 1.17
The Ig-related killer cell inhibitory receptor binds zinc and requires zinc for recognition of HLA-C on target cells. J Immunol (1995) 1.12
Energy migration alters the fluorescence lifetime of Cerulean: implications for fluorescence lifetime imaging Forster resonance energy transfer measurements. J Biomed Opt (2008) 1.10
Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells. J Immunol (1998) 1.10
Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc Natl Acad Sci U S A (1996) 1.09
Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs. J Biol Chem (1997) 1.08
The adaptor protein Crk controls activation and inhibition of natural killer cells. Immunity (2012) 1.07
Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors. J Immunol (1999) 1.06
KIR enrichment at the effector-target cell interface is more sensitive than signaling to the strength of ligand binding. Eur J Immunol (2003) 1.03
Photophysical properties of Cerulean and Venus fluorescent proteins. J Biomed Opt (2009) 1.01
Plasmon-controlled fluorescence: A new detection technology. Proc SPIE Int Soc Opt Eng (2006) 0.90
FcR-mediated inhibition of cell activation and other forms of coinhibition. Crit Rev Immunol (1998) 0.85
TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes. Int Immunol (2007) 0.81